I. E. Smith
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 3
-
- Breast Cancer Treatment Studies 10
- Co-authors
- D Steele (1 shared paper)Susana Banerjee (1 shared paper)S. Ashley (1 shared paper)A. Ashworth (1 shared paper)Jorge S. Reis‐Filho (1 shared paper)Sunil R. Lakhani (1 shared paper)Janine Salter (3 shared papers)Martin Gore (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (2 papers)Postgraduate Medical Journal (2 papers)Clinical Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesEstonia
In The Last Decade
I. E. Smith
24 papers receiving 747 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 289
- Oncology 372
- Genetics 143
- Pathology and Forensic Medicine 76
- Hematology 46
Countries citing papers authored by I. E. Smith
This map shows the geographic impact of I. E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. E. Smith more than expected).
Fields of papers citing papers by I. E. Smith
This network shows the impact of papers produced by I. E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. E. Smith. The network helps show where I. E. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside I. E. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 235 | |
| 2 | HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. | 2001 | 150 |
| 3 | 2001 | 70 | |
| 4 | 1987 | 58 | |
| 5 | 2011 | 53 | |
| 6 | 1976 | 47 | |
| 7 | 2005 | 33 | |
| 8 | 2009 | 30 | |
| 9 | 2025 | 23 | |
| 10 | 1977 | 18 | |
| 11 | 1996 | 10 | |
| 12 | Carcinoid tumour presenting as an orbital metastasis. | 1981 | 9 |
| 13 | 2011 | 8 | |
| 14 | 2009 | 6 | |
| 15 | 2009 | 6 | |
| 16 | 2018 | 5 | |
| 17 | 1994 | 3 | |
| 18 | 1977 | 2 | |
| 19 | 2004 | 2 | |
| 20 | 1985 | 2 |
About I. E. Smith
I. E. Smith is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 25 papers that have together received 774 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Estrogen and related hormone effects (8 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (3 papers), Neuroblastoma Research and Treatments (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Cancer Research (289 citations), Oncology (372 citations), Genetics (143 citations), Pathology and Forensic Medicine (76 citations) and Hematology (46 citations). I. E. Smith has collaborated with scholars based in United Kingdom, United States and Estonia. Frequent co-authors include D Steele, Susana Banerjee, S. Ashley, A. Ashworth, Jorge S. Reis‐Filho, Sunil R. Lakhani, Janine Salter, Martin Gore, Mitch Dowsett and A. Hilary Calvert. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Postgraduate Medical Journal, Clinical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.